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                               Abstraet
   A transdermal therapeutic system can be developed by promoting the skin permea-
bility of drugs with some materiars. In this study, the prornoting effect of terpenes
present in essential oils on the percutaneous absorption of indomethacin from alcoholic
hydrogels was investigated in rats in vive. The enhancing activity of terpenes was
expressed quantitatively as a quadratic function of lipophilicities of the terpenes, measured
as a lipophilic index. Further increase in the significant level was observed when the
molecular weight of terpenes was included in this function as the second factor. The
synergism of ethanol with d-limonene, selected from among the other terpenes, on the
promoting activity was statistically investigated. It was evident that both d-limonene
and ethanol were important factors for promoting the percutaneous absorption of in-
domethacin. A significant synergism of d-limonene with ethanol was also observed. As
a possible mechanism for enhancement action of d-limonene and ethanol, it was considered
that, at first, d-limonene penetrates into the skin under coexistence with ethanol and may
change the barrier structure of the straturn corneum. The transfer of ethanol to the
skin is thereby enhanced under the coexistence with d-!imonene in the skin. Thus, the
the permeation of indomethacin can be promoted due to its aMnity with ethanol.
                                   Introduction
   The transdermal route for drug administration is limited by the barrier properties of
the stratum corneumi). The intercellular region has been identified as the major route of
transdermal penetration of drug molecules2). Barrier properties of the stratum corneum
may be manipulated by using skin permeation enhancers. Therefore, the possibility of
using many synthesized or naturally occurring compounds as effective enhancers has been
investigated. Recently, we have investigated the promoting effect of mono-, sesqui- and
diterpenes present in essential oils on the percutaneous absorption of nonsteroidal antiin-
flammatory drugs such as indomethacin and ketoprofen from the hydrogels in rats3-iO'.
Monoterpenes such as menthane, limonene, terpinene and terpinolene exhibited a pronounced
activity on the percutaneous absorption of these drugs under the coexistence of ethanol.
A possible mechanism of action for d-limonene, which is the main component of orange
or lemon oils, was investigated in detail, since this compound is considered to have a
Pragmatic meritii-i3).
                           Promoting Effect of Terpenes
   The effect of different kinds of terpenes on the percutaneous absorption of indomethacin
was investigated in rats, in vivo3•'`). Results are given in LTable 1. The absorption of
indomethacin was remarkably enhanced by the addition of hydrocarbons of cyclic mono-
terpenes such as menthane, limonene, terpinene and terpinolene3). On the other hand, no
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    Table 1. Effect of terpenes on the
            hydrogels in rats.
percutaneous absorptlon of indomethacin from
Terpenes
Plasma concentration (mgll)
2h 4h 6h 8h
 AUC(mg. hll)
Monoterpenes
   cis-P-menthane
   trans-P-menthane
   d-limonene
   l-limonene
   dl-limonene
   cr-terpmene
   terpinolene
Sesquiterpenes
   a-caryophyllene
   iongifolene
   farnesol
   nerolidol
Diterpenes
   phytol
   isophytol
   geranyl-linalool
Control
   (without terpene)
3.2Å}O.7
3.4Å}O.6
5.9Å}1.8
2.9Å}2.8
3.6Å}1.3
2.9+1.0
5.4Å}2.3
1.1Å}O.2
11.5Å}O.8
15.1Å}4.3
15.6Å}3.6
12.0Å}4.7
14.8Å}2.9
 8.3Å}1.9
19.8Å}5.3
 1.6Å}O.8
 O.8Å}O.1
6.8Å}2
2.4Å}1
6.2Å}1
.5
.4
.5
20.0Å}O.5
27.7Å}9.7
21.9Å}4.1
24.3Å}3.9
26.9Å}5.1
11.6Å}3.5
32.6Å}5.3
 3.0Å}1.4
 1.8Å}O.4
 8.9+O.5
 O.4+O.3
11.9Å}3.4
 6.1Å}3.5
11.1Å}1.5
27.9Å}1.8
34.0Å}8.4
29.5Å}5.5
31.2Å}5.1
31.6Å}5.1
16.8Å}6.1
46.4Å}2.7
 6.0Å}2.2
 3.2Å}O.9
13.9Å}1.6
 1.5Å}O.8
13.9Å}3.7
11.8Å}3.8
15.0Å}1.5
97.3Å} 5.8
126,4+37.6
113.4Å}23.3
109.6Å}27.9
122.2Å}23.7
 62.4Å}18.9
162.0Å}28.5
 15.7Å} 7.2
 8.3Å} 1.7
 34.1Å} 2.8
 3.3Å} 2.8
 55.5Å}11.8
29.1Å}10.6
 51.7Å} 7.6
   Each hydrogel contains 1iOo"'
meanz-LSD (n=3-5). - indicates
mg!l).
indomethacin, 1%
 that the plasma
terpene and
concentratlon
so% ethafi6Til Eac/il7i5'iue re- i resefitl"the
 fell under the limit of detection (ÅqO.5
significant promotlng effect was observed when monoterpenes containing hydroxyl or car-
bonyl groups, or ether oxygen were employed (e.g., menthol, menthone or cineole). We
also found very strong activity of hydrocarbons such as d-limonene on the percutaneous
absorption of ketoprofen`'. Barry and Williams reported that 1,8-cineole was the most
effective on in vitro permeation of 5-fluorouracil through human cadaver skin, while the
activity of hydrocarbons was poori5•i6). Eucalyptus oil and camphor promote the flux of
nicotine through excised hairless mouse skini". Terpineol and acetyl terpineol promote
in vitro diffusion of prednisolone through hairless mouse skin'8', Lately we found l-menthol
to be the most effective absorption promoter among cyclic monoterpenes on the percu-
taneous absorption of diclofenac sodium from gel ointments in ratsi9). Although significant
promoting activity was observed when using sesqui- and diterpenes (Table 1), the promoting
effect of these compounds was rather poor, when compared with the hydrocarbon mono-
terpenes.
                        Physieochemical Property of Terpenes
    The lipophilicities of all compounds were measured as a lipophilic index (LI)20'. It
will be seen that terpenes with relatively high LI values exhibited absorption promoting
effects, whereas too strong Iipophilicity led to the lower promoting activities. Thus, the
optimal lipophilicity of the terpenes may exist for their promoting activities. In order to
know the quantitative relationship, the area under the curve of plasma concentration of
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indomethacin versus the application time of the hydrogel for up to 8 h (AUC) was calculated
as an index for evaluating the absorption of indomethacin. A quadratic equation for the
AUC values listed in Table 1 was obtained as a function of LI.
                   AUC=-649(Å}273)LI2+222(Å}119)LI+90.1(Å}23.5) (1)
                        n=14, r=O.79, Fo=9.13 (PÅqO.Ol)
where r is multiple correlation coeMcient, and Fo is a ratio of mean square regression to
mean square residual. Each monomial in Eqn 1 was considered to be significant with
significantly high Fo value, though the r value was not suMcient. When a molecular
weight (MW) of terpenes was included in Eqn1 as the second factor, further increase in
significant levels was observed.
           AUC==-474(Å}288)LI2+174(Å}114)LI-8.98(Å}7.95)VM'W'M+205(Å}104) (2)
                        n= 14 , r =O.86 , Fo =9.25 (PÅqO.Ol)
Results predicted by Eqns1and2 are shown in Fig. 1. The optimal value of LI was
calculated to be O.17 from Eqn 1 and O.18 from Eqn 2. It has been generally understood
in analogous compounds that the diffusion coeficient of molecules is inversely proportional
to the square or cube root of their molecular weights. This may suggest the smaller
molecule could easily permeate into the skin. Accordingly, the terpenes with a small
molecular weight and an adequate lipophilicity might be desirable for exhibiting promoting
activities.
   In order to estimate the thermodynamic nature of indomethacin in the hydrogel, the
effect of terpenes on the solubility of indomethacin and the partition coeMcient of indo-
methacin between octanol and the buffer solution (pH 7.2) were determined. As for the
solubility, a 70% ethanol-water solution was employed instead of the hydrogel, because an
accurate determination of solubility in the gel was dithcult due to its high viscosity, In
addition, a relatively high concentration of ethanol was required in order to dissolve all
of the terpenes. Since the solubility and partition coeflicient of indomethacin were hardly
affected by the addition of terpenes, the promoting activities observed in several terpenes
could arise from direct effects of these compounds on the barrier properties of the skin.
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                         Synergism of Limonene and Ethanol
    The combined effect of d-limonene and ethanol on the promoting activity was inves-
tigated in detail. d-Limonene was selected from among the other terpenes for pragmatic
reasons. It is readily available as the main component in orange or lemon oils, and its
toxicity to the skin is considered to be low. On the other hand, the promoting effect of
ethanol on the percutaneous absorption of drugs has been reported in the literature2'•22'.
Fig. 2 shows the effect of differing concentrations of d-limonene and ethanol on the percu-
taneous absorption of indomethacin in rats. When the concentration of d-limonene was
low in the ointment, plasma levels of indomethacin increased proportionally with an in-
crease in the amount of ethanol. Especially at the higher concentrations of d-limonene,
Fig. 2.
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a remarkable increase in the plasma level of indomethacin was observed due to the change
in ethanol concentration from 30 to 40%. However, any further increase in ethanol concen-
tration (from 40 to 50%) resulted in only a slight enhancement of the percutaneous absorp-
tion of indomethacin. The AUC values of indomethacin were again calculated from Fig. 2
and visually represented as a function of d-limonene and ethanol concentrations as shown
in Fig. 3. It will be seen that at least 2% d-limonene and 40% ethanol were required to
obtain conspicuous promoting effects. In order to elucidate the synergism of d-limonene
and ethanol statistically, an ANOVA technique was applied to the AUC values. As a
result, it was evident that d-limonene and ethanol were very important factors for enhanc-
ing the AUC values. Although the value of Fo in the interaction term wassomewhat low,
the synergism of d-limonene and ethanol on percutaneous absorption was significantly
observed.
                        Meehanism of Promoting Action
   Fig. 4 shows the relationship between indomethacin concentrations observed in the
skin and in plasma at 2 and 8h after application of the hydrogels containing 1% indome-
thacin, 1-3% d-limonene and 50% ethanol. In both skin and plasma, the concentration of
indomethacin increased linearly as a function of d-limonene in the hydrogels. The plasma
concentration of indomethacin was nearly proportional to the amount of indomethacin
accumulated in the skin, suggesting that the rate-limiting step on the absorption of in-
domethacin was the penetration process frorn the hydrogel to the skin rather than the
process from the skin to the blood circulation. The effect of differing concentrations of
d-limonene formulated in the hydrogel on the accumulation of ethanol in the skin was
investigated. Since ethanol and d-limonene have high volatility, values measured at the
initial stage (2h) after application were mutually compared. Fig. 5 shows the relationship
between the amounts of ethanol and indomethacin accumulated in the skin at 2h after
application of the hydrogels, Increasing the concentration of d-limonene in the hydrogels
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Fig. 4. Relationship between concentrations of indomethacin observed in skin and in
      plasma at 2h (A) and 8h (B) after application of hydrogels containing 1%
      indomethacin and 50% ethanol in rats. a, 1% d-limonene; b, 2% d-limonene;
      c, 3% d-limonene. The concentration in the skin is represented as the meanÅ}SD
      (n=3). The plasma concentration is represented as the meanÅ}SD (n=:5).
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     Fig. 5. Relationship between concentrations of ethanol and indomethacin accumulated
            in skin at 2h after application of hydrogels in rats. a, 1% d-limonene; b, 2%
            d-limonene; c, 3% d-limonene. Each point represents the meanÅ}SD (n=3).
was directly proportional to the transfer of ethanol to the skin. Furthermore, the amount
of ethanol accumulated in the skin was closely associated with that of indomethacin. The
solubility of indomethacin in ethanol at 300C (26.1 g!1) was approximately 40 times greater
than that in d-limonene (O.644g!1). Therefore, the penetration of indomethacin from the
hydrogel to the skin might be promoted with an increasing amount of ethanol accumulated
in the skin. Although the amount of d-limonene accumulated in the skin was measured
similarly to indomethacin and ethanol, the evaluation of the data was diMcult due to its
large deviation. Based on the result described above, a possible mechanism for the enhance-
ment action of d-limonene and ethanol may be explained as follows: At first, d-limonene
penetrates into the skin under the coexistence with ethanol and may change the barrier
structure of the skin; the transfer of ethanol to the skin is thereby accelerated under the
coexistence with d-limonene in the skin; thus, the permeation of indomethacin could be
promoted due to its high athnity with ethanol.
   Since the intercellular lipids of the stratum corneum provide the principal barrier to
the percutaneous absorption2', primary active site of cyclic monoterpenes is considered as
being at the lipid bilayer in the intercellular region of the stratum corneum. The mech-
anism of promoting action of these terpenes was investigated, employing a phospholipid
liposome composed of dipalmitoylphosphatidylcholine (DPPC), dicetyl phosphate (DCP) and
cholesterol, as a simple model to represent the intercellular lipid structure in the stratum
corneum. DCP gives a negative charge on the surface of liposome and protects a coagula-
tion among the liposome particles. The molar ratio of DPPC, DCP and cholesterol was
fixed to be 10:1:2. Structure change of lipid bilayer in the liposomes, which was brought
about by the addition of terpenes, was monitored by means of DSC, ESR and fluorescence
polarization measurements. As a result, enhancing activity of terpenes was correlated well
with the transition temperature or transition enthalpy change, suggesting that terpenes,
which have strong effect on the liposome membrane, bring about a strong enhancing action
on the percutaneous absorption of indomethacin. From the measurements of ESR and
fluorescence polarization, fluidizing effect of terpenes on the lipid bilayer structure was
observed when the liposome contained suMcient amount of cholesterol (;)20mol%) as a
membrane component. More hydrophobic compounds such as d-limonene among the ter-
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penes showed stronger eflect on the fluidity of the lipid bilayer.
                                   Conclusion
   Hydrocarbons of cyclic monoterpenes such as d-limonene exhibited a very strong activity
on the percutaneous absorption of indomethacin under the coexistence of ethanol. The
enhancing activities of terpenes were quantitatively predicted as a function of lipophilic
index of these compounds. When a molecular weight of terpenes was included as the
second factor in this function, further increase in significant levels was observed. It may
suggest that the terpenes with a small molecular weight and an adequate lipophilicity are
desirable for exhibiting promoting activities. The combined effect of d-limonene and
ethanol was significantly observed, and 2% d-limonene and 40% ethanol was close to the
optimal condition which will provide an excellent promoting effect and safety to the skin.
A possible mechanism for the enhancement action was explained as follows: At first, d-
limonene penetrates into the skin under the coexistence with ethanol and may change the
barrier structure of the skin: the transfer of ethanol to the skin is thereby accelerated
under the coexistence with d-limonene in the skin; thus, the permeation of indomethacin
could be promoted due to its athnity with ethanol. Primary active site of terpenes was
considered as being at the lipid bilayer in the intercellular region of the stratum corneum.
More hydrophobic compounds such as d-limonene among the terpenes showed stronger
effect on the fluidity of the lipid bilayer.
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